Literature DB >> 22678705

A novel mutation in PRG4 gene underlying camptodactyly-arthropathy-coxa vara-pericarditis syndrome with the possible expansion of the phenotype to include congenital cataract.

Nadia A Akawi1, Bassam R Ali, Lihadh Al-Gazali.   

Abstract

BACKGROUND: Camptodactyly-arthropathy-coxa vara-pericarditis syndrome (CACP) is a clinically heterogenous congenital disorder caused by mutations in proteoglycan 4 (PRG4), a chondroitin sulfate proteoglycan that acts as a lubricant for the cartilage surface. Although CACP is a rare genetic disorder, several cases were described in the literature from ethnically different populations including Caucasian, Egyptian, Saudi Arabian, Pakistani, and Korean. We report CACP for the first time in United Arab Emirates.
METHODS: Direct sequencing of all the coding exons and splice sites of the PRG4 gene was performed for all the members of the affected family.
RESULTS: The studied family is consanguineous and has multiple affected members from different branches showing congenital camptodactyly with arthropathy, the hallmarks of CACP. All the affected family members lack pericarditis, but one of them was born with cataract, which has never been documented in any of the previously reported cases of CACP. Molecular analysis revealed a novel homozygous insertion of a cytosine nucleotide (c.1320dupC) in the highly repetitive portion of the coding sequence of the PRG4 gene. The detected mutation caused a frameshift in the cDNA sequence and created a premature termination codon (p.P440fsX197), which is likely to result in a nonfunctional protein.
CONCLUSION: We report a family from the United Arab Emirates with typical features of CACP in whom one of the children had in addition, a bilateral congenital cataract. We also report the identification of a novel null mutation in PRG4 confirming the genetic homogeneity of CACP.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22678705     DOI: 10.1002/bdra.23031

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  6 in total

1.  Monogenic disorders as mimics of juvenile idiopathic arthritis.

Authors:  Laura Furness; Phil Riley; Neville Wright; Siddharth Banka; Stephen Eyre; Adam Jackson; Tracy A Briggs
Journal:  Pediatr Rheumatol Online J       Date:  2022-06-18       Impact factor: 3.413

2.  Genomics into Healthcare: the 5th Pan Arab Human Genetics Conference and 2013 Golden Helix Symposium.

Authors:  Paolo Fortina; Najib Al Khaja; Mahmoud Taleb Al Ali; Abdul Rezzak Hamzeh; Pratibha Nair; Federico Innocenti; George P Patrinos; Larry J Kricka
Journal:  Hum Mutat       Date:  2014-03-31       Impact factor: 4.878

3.  CACP syndrome: identification of five novel mutations and of the first case of UPD in the largest European cohort.

Authors:  Sara Ciullini Mannurita; Marina Vignoli; Lucia Bianchi; Anuela Kondi; Valeria Gerloni; Luciana Breda; Rebecca Ten Cate; Maria Alessio; Angelo Ravelli; Fernanda Falcini; Eleonora Gambineri
Journal:  Eur J Hum Genet       Date:  2013-06-12       Impact factor: 4.246

4.  Novel mutations in PRG4 gene in two Indian families with camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome.

Authors:  Rajashree S Nandagopalan; Shubha R Phadke; Ashwin B Dalal; Prajnya Ranganath
Journal:  Indian J Med Res       Date:  2014-08       Impact factor: 2.375

5.  The Efficacy of Yttrium-90 Radiosynovectomy in Patients with Camptodactyly-Arthropathy-Coxa Vara-Pericarditis Syndrome.

Authors:  Sulaiman Mohammed Al-Mayouf; Nora Almutairi; Khalid Alismail
Journal:  Mol Imaging Radionucl Ther       Date:  2017-02-05

6.  Genotype-phenotype investigation of 35 patients from 11 unrelated families with camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome.

Authors:  Saliha Yilmaz; Dilek Uludağ Alkaya; Özgür Kasapçopur; Kenan Barut; Ekin S Akdemir; Cemre Celen; Mark W Youngblood; Katsuhito Yasuno; Kaya Bilguvar; Murat Günel; Beyhan Tüysüz
Journal:  Mol Genet Genomic Med       Date:  2018-02-04       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.